Future Medicine India – Doctor’s Interviews Medical devices and gadgets Straight Talk Archives | Future Medicine India

Straight Talk

“After NABH assessment, medication error reporting has risen to nearly 100%”

Along with a distinguished career in the Army Medical Corps (AMC), Air Marshal (Dr) Pawan Kapoor has also been one of the strongest voices in India’s Healthcare Quality movement. He has been a founder member of the NABH and continues to serve as a mentor to the NABH. He retired in December 2017 as Director-General, […]

DR SUMIT GHOSHAL
Read More..

“We wanted to address all issues that hindered early detection of breast cancer”

Breast cancer is the most common cancer among Indian women in terms of incidence as well as mortality. Its prevalence in younger age-groups in India is higher than the global average.

CH Unnikrishnan

“We want to support, groom and recognise young, brilliant doctors”

For Metropolis, the next level of growth is not merely chasing business but making an impact in the community with the science that it deals with.

C H Unnikrishnan

“PRICING IT AT RS 8,000, WE WILL BE ABLE TO DISRUPT THE NIPT MARKET IN INDIA”

Thyrocare Technologies Ltd, which disrupted India’s biochemistry tests and general diagnostics scene with rock bottom prices more than a decade ago and grabbed a sizable share in the Rs 40,000 crore market, has now entered the NGS segment

C H UNNIKRISHNAN

“We still don’t have a clear understanding of the actual disease burden in India”

Vijay Chandru, Co-Founder and Director, Strand Life Sciences, and INAE Distinguished Technologist at Indian Institute of Science, is an academic turned entrepreneur.

CH Unnikrishnan

“The debate on whether to undergo surgery or stenting is still very, very active”

Dr Patrick Serruys is one of the greatest authorities on angioplasty and coronary stenting in the world today. Currently, he is the Director of the Clinical Research Program of the Catheterization Laboratory,

Dr Sumit Ghoshal

“Everybody has to develop the way they are. Taking advice is like copying someone”

There are quite a few in the development stage across the globe, targeting ribosomes. But, in general, it seems that many of the big companies do not think that antibiotics are a profitable business for them.

C H Unnikrishnan.